Seagen Inc (SGEN)

Precedente Chiudi:

$228.74

Aprire:

$0

Volume 24 ore:

0

Capitalizzazione di mercato:

$43.15B

Reddito:

$2.30B

Utile/perdita netta:

$-750.23M

Rapporto P/E:

0.00

EPS:

-4.01

Flusso di cassa netto:

$-701.21M

1 W Prestazione:

-100.00%

1M Prestazione:

-100.00%

6M Prestazione:

-100.00%

1 anno Prestazione:

-100.00%

Intervallo 1D:

$0.00

$0.00

Portata 52W:

$0.00

$228.96

Seagen Inc Stock (SGEN) Company Profile

Nome

Seagen Inc

Settore

Healthcare (1191)

Industria

Biotechnology (688)

Telefono

425-527-4000

Indirizzo

21823 30th Drive SE, Bothell, WA

Dipendente

1,100

Cinguettio

@seattlegenetics

Prossima data di guadagno

2023-11-01

Ultimi documenti SEC

SGEN's Discussions on Twitter

Seagen Inc Stock (SGEN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-02-16	Aggiornamento	Evercore ISI	In-line → Outperform
2023-02-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2023-02-06	Downgrade	SVB Securities	Outperform → Market Perform
2022-11-21	Iniziato	Truist	Hold
2022-10-11	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2022-06-29	Iniziato	Raymond James	Outperform
2022-06-24	Iniziato	BMO Capital Markets	Market Perform
2022-02-10	Reiterato	BofA Securities	Buy
2022-02-10	Reiterato	H.C. Wainwright	Buy
2022-02-10	Reiterato	Morgan Stanley	Overweight
2022-02-10	Reiterato	Needham	Buy
2022-02-10	Reiterato	Piper Sandler	Neutral
2022-02-10	Reiterato	RBC Capital Mkts	Sector Perform
2022-02-10	Reiterato	SVB Leerink	Outperform
2022-02-10	Reiterato	Wolfe Research	Peer Perform
2022-01-31	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-11-09	Iniziato	Wolfe Research	Peer Perform
2021-10-15	Ripresa	BTIG Research	Neutral
2021-05-17	Iniziato	Evercore ISI	In-line
2021-03-31	Iniziato	Credit Suisse	Neutral
2021-02-01	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2021-01-15	Aggiornamento	BofA Securities	Neutral → Buy
2020-09-22	Reiterato	Stifel	Hold
2020-08-24	Ripresa	Berenberg	Buy
2020-07-31	Reiterato	H.C. Wainwright	Buy
2020-07-24	Downgrade	Piper Sandler	Overweight → Neutral
2020-05-26	Iniziato	JMP Securities	Mkt Outperform
2020-05-01	Aggiornamento	Guggenheim	Neutral → Buy
2020-05-01	Reiterato	Needham	Buy
2020-02-18	Downgrade	Barclays	Overweight → Equal Weight
2020-02-12	Reiterato	H.C. Wainwright	Buy
2020-02-11	Reiterato	Goldman	Buy
2020-01-28	Iniziato	BMO Capital Markets	Outperform
2020-01-27	Iniziato	BMO Capital Markets	Outperform
2020-01-02	Downgrade	Guggenheim	Buy → Neutral
2019-12-10	Iniziato	Morgan Stanley	Equal-Weight
2019-12-03	Ripresa	BofA/Merrill	Neutral
2019-10-22	Reiterato	BofA/Merrill	Underperform
2019-10-22	Reiterato	H.C. Wainwright	Buy
2019-09-27	Aggiornamento	Goldman	Neutral → Buy
2019-08-26	Iniziato	BTIG Research	Neutral
2019-07-18	Iniziato	Deutsche Bank	Hold

Mostra tutto

Seagen Inc Borsa (SGEN) Ultime notizie

Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast

Benzinga

Pfizer (PFE) Stock Sinks on Weak 2024 View as COVID Sales Fall

Zacks Investment Research

Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?

The Motley Fool

Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'

Benzinga

Bristol Myers Squibb's Mega $8.4B Oncology Bet - Secures Exclusive License With SystImmune

Benzinga

Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?

Zacks Investment Research

Seagen Inc Azioni (SGEN) Dati Finanziari

Seagen Inc (SGEN) Reddito 2024

Seagen Inc (SGEN) Reddito netto 2024

Seagen Inc (SGEN) Flusso di cassa 2024

Seagen Inc (SGEN) Utile per azione 2024